Here are stocks that are in news today:
Results today: Bajaj Finance, Bajaj Finserv, Mindtree, Canara Bank, Havells India, KPIT Technologies, Mastek, GNA Axles, Sutlej Textiles, MPS, Sanofi India, Sterlite Technologies, Jubilant Industries
HUL Q1
-Net profit up 9.3 percent at Rs 1,283 crore versus Rs 1,174 crore (YoY)
-Revenue up 4.7 percent at Rs 9,222 crore versus Rs 8,802 crore (YoY)
-EBITDA up 20.2 percent at Rs 1,866 crore versus Rs 1,552 crore (YoY)
-EBITDA margin at 21.9 percent versus 19.1 percent (YoY)
-Homecare revenue up 5.9 percent at Rs 3,047 crore versus Rs 2,876 crore (YoY)
-Homecare EBIT up 25.8 percent at Rs 448 crore versus Rs 356 crore (YoY)
-Personal care revenue up 3.5 percent at Rs 4,368 crore versus Rs 4,222 crore (YoY)
-Personal care EBIT up 5.7 percent at Rs 1,079 crore versus Rs 1,021 crore (YoY)
-Refreshments revenue up 10.8 percent at Rs 1,346 crore versus Rs 1,215 crore (YoY)
-Refreshments EBIT up 32.8 percent at Rs 255 crore versus Rs 192 crore (YoY)
HT Media Q1
-Consolidated net profit up 85.4 percent at Rs 41.5 crore versus Rs 22.4 crore (YoY)
-Consolidated revenue down 2.5 percent at Rs 599 crore versus Rs 614.7 crore (YoY)
-Consolidated EBITDA up 24.3 percent at Rs 80 crore versus Rs 64.3 crore (YoY)
-Consolidated EBITDA margin at 13.3 percent versus 10.4 percent (YoY)
Jet Airways: Sources
-Jet Airways looks to phase out its smaller aircraft
-Jet Airways in talks with TruJet to sublease its ATR aircraft
-Jet Airways currently has a fleet of 18 smaller aircraft
-Subleasing to TruJet will happen in a phased manner
-TruJet is a regional airline, operates 4 ATR aircraft
-ATRs not fitting in with Jet's premium push & international focus
-TruJet plans to focus on regional connectivity under UDAAN scheme
-Jet Airways to CNBC-TV18: As a policy, company does not comment on speculation
JM Financial
-Subsidiary acquires 8.5 percent in Spandana Sphoorty
-Spandana is engaged in the business of micro finance lending
Other stocks and sectors that are in news today:
-Aurobindo Pharma gets US FDA approval for Sevelamer tablets (used to treat patients with chronic kidney diseases)
-Lupin gets US FDA nod for Armodafinil (used to treat excessive sleeping disorder)
-Sun Pharma gets US FDA nod for Paroxetine Hydrochloride (used to treat OCD, panic attacks)
-Zydus Pharma gets US FDA nod for Pitavastatin (helps lower 'bad' cholesterol & raise 'good' cholesterol)
-Glenmark Pharma enters into exclusive agreement with Cyndea for generic soft-gelatin capsule drug products
-Ashok Leyland enters into strategic alliance for electric mobility solutions with Sun Mobility
-Kala Amb Transmission, wholly owned subsidiary of Power Grid, commissions project
-Zee Entertainment acquires 100 percent in Fly by Wire for Rs 1.4 crore
-Religare - ICRA revises rating to A+ from AA- on long term debt program
-KKR starts bankruptcy proceedings against Amtek Auto's overseas assets: Mint
-Tata Power to invest USD 90 million in renewablew energy arm TPREL: Mint
-Crompton, Videocon in focus - PE's backed Crompton may offer Rs 1,500 crore for Kenstar: ToI
-Monnet Ispat declared insolvent despite JSW offer: BS
-CCI approves acquisition of 20 percent stake in Paytm's parent One97 Communications by Softbank Group
-Credit Suisse removes ITC from Asia Ex-Japan focus list
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
